NRC Advisory Committee to Discuss Proposed Rules on Medical Uses of Radioactive Material

---

	NRC NEWS U. S. NUCLEAR REGULATORY COMMISSION
	Office of Public Affairs	Telephone: 301/415-8200
	Washington, DC 20555-001	E-mail: opa@nrc.gov

---

No. 98-22

February 2, 1998

NRC ADVISORY COMMITTEE TO DISCUSS PROPOSED RULES
ON MEDICAL USES OF RADIOACTIVE MATERIAL

The Nuclear Regulatory Commission's Advisory Committee on Medical Uses of Isotopes and two of its subcommittees have scheduled meetings to discuss proposed revisions to the agency's regulations on medical uses of radioactive material. The meetings are open to the public.

The full committee will meet March 1 and 2 at Two White Flint North, Room T2B3, 11545 Rockville Pike, Rockville, Maryland. The meeting will begin at 8:00 each morning. In addition to the proposed changes to the regulations on medical uses of radioactive materials, the committee will discuss the calibration and correct use of Strontium-90 eye applicators, current training and experience requirements to conduct certain types of treatments using radioactive material, criteria for evaluation of committee performance, and previous committee recommendations.

Persons wishing to submit written statements on this full committee meeting should mail them by February 20 to Patricia Vacherlon, U.S. Nuclear Regulatory Commission, Office of Nuclear Material Safety and Safeguards, Washington, DC 20555.

The first subcommittee meeting will be held February 9 and 10 in Room T2B1 in the same building in Rockville, Maryland. It also will begin at 8:00 each morning and will focus on the proposed rule changes that relate to use of radioactive materials to diagnose diseases.

The second subcommittee meeting will be February 12 and 13 at the Leonard C. Ferguson Cancer Center, 1163 W. Stephenson Street, Freeport, IL 61032. It will begin at 8:30 a.m. each morning and will end at about 5:00 p.m. on February 12 and 3:00 p.m. on February 13. This meeting will focus on proposed rule changes involving the use of radioactive materials to treat diseases.

Persons wishing to submit written statements on the subcommittee meetings should mail them by February 2 to Patrician Vacherlon at the above address.